Gilead beats Street 4Q forecasts
The Foster City, California-based company said it had profit of $2.34 per share. Earnings, adjusted for costs related to mergers and acquisitions and stock option expense, came to $2.70 per share.
from Biotech News
The Foster City, California-based company said it had profit of $2.34 per share. Earnings, adjusted for costs related to mergers and acquisitions and stock option expense, came to $2.70 per share.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments